259 related articles for article (PubMed ID: 33944881)
1. Effect of Adjuvant Metronomic Capecitabine on Disease-Free Survival Among Patients With Early-Stage Triple-Negative Breast Cancer.
Du F; Yuan P
JAMA; 2021 May; 325(17):1791-1792. PubMed ID: 33944881
[No Abstract] [Full Text] [Related]
2. Effect of Adjuvant Metronomic Capecitabine on Disease-Free Survival Among Patients With Early-Stage Triple-Negative Breast Cancer.
Chakrabarti D; Akhtar N; Kumar V
JAMA; 2021 May; 325(17):1792-1793. PubMed ID: 33944880
[No Abstract] [Full Text] [Related]
3. Effect of Adjuvant Metronomic Capecitabine on Disease-Free Survival Among Patients With Early-Stage Triple-Negative Breast Cancer-Reply.
Bi XW; Hua X; Yuan ZY
JAMA; 2021 May; 325(17):1793. PubMed ID: 33944878
[No Abstract] [Full Text] [Related]
4. Metronomic capecitabine as extended adjuvant chemotherapy in women with triple negative breast cancer.
Alagizy HA; Shehata MA; Hashem TA; Abdelaziz KK; Swiha MM
Hematol Oncol Stem Cell Ther; 2015 Mar; 8(1):22-7. PubMed ID: 25528114
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy.
Masuda N; Lee SJ; Ohtani S; Im YH; Lee ES; Yokota I; Kuroi K; Im SA; Park BW; Kim SB; Yanagita Y; Ohno S; Takao S; Aogi K; Iwata H; Jeong J; Kim A; Park KH; Sasano H; Ohashi Y; Toi M
N Engl J Med; 2017 Jun; 376(22):2147-2159. PubMed ID: 28564564
[TBL] [Abstract][Full Text] [Related]
6. Additional adjuvant capecitabine in early breast cancer patients: a meta-analysis of randomized controlled trials.
Zhou W; Cao Y; Gou P; Zeng X; Hu X; Lin Z; Ye C; Chen L; Yao G
Future Oncol; 2021 Dec; 17(35):4993-5002. PubMed ID: 34689590
[TBL] [Abstract][Full Text] [Related]
7. Phase III Trial of Adjuvant Capecitabine After Standard Neo-/Adjuvant Chemotherapy in Patients With Early Triple-Negative Breast Cancer (GEICAM/2003-11_CIBOMA/2004-01).
Lluch A; Barrios CH; Torrecillas L; Ruiz-Borrego M; Bines J; Segalla J; Guerrero-Zotano Á; García-Sáenz JA; Torres R; de la Haba J; García-Martínez E; Gómez HL; Llombart A; Bofill JS; Baena-Cañada JM; Barnadas A; Calvo L; Pérez-Michel L; Ramos M; Fernández I; Rodríguez-Lescure Á; Cárdenas J; Vinholes J; Martínez de Dueñas E; Godes MJ; Seguí MA; Antón A; López-Álvarez P; Moncayo J; Amorim G; Villar E; Reyes S; Sampaio C; Cardemil B; Escudero MJ; Bezares S; Carrasco E; Martín M; ; ;
J Clin Oncol; 2020 Jan; 38(3):203-213. PubMed ID: 31804894
[TBL] [Abstract][Full Text] [Related]
8. Preliminary results of capecitabine metronomic chemotherapy in operable triple-negative breast cancer after standard adjuvant therapy--a single-arm phase II study.
Shawky H; Galal S
J Egypt Natl Canc Inst; 2014 Dec; 26(4):195-202. PubMed ID: 25467387
[TBL] [Abstract][Full Text] [Related]
9. Capecitabine in early breast cancer: A meta-analysis of randomised controlled trials.
Natori A; Ethier JL; Amir E; Cescon DW
Eur J Cancer; 2017 May; 77():40-47. PubMed ID: 28355581
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant Capecitabine in Triple-Negative Breast Cancer: New Strategies for Tailoring Treatment Recommendations.
Parsons HA; Burstein HJ
JAMA; 2021 Jan; 325(1):36-38. PubMed ID: 33300953
[No Abstract] [Full Text] [Related]
11. Additional capecitabine use in early-stage triple negative breast cancer patients receiving standard chemotherapy: a new era? A meta-analysis of randomized controlled trials.
Ye F; Bian L; Wen J; Yu P; Li N; Xie X; Wang X
BMC Cancer; 2022 Mar; 22(1):261. PubMed ID: 35279130
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant capecitabine for early triple-negative breast cancer: A meta-analysis of randomized controlled trials.
Liu M; Fang H; Qian S
Asian J Surg; 2022 Sep; 45(9):1748-1750. PubMed ID: 35168861
[No Abstract] [Full Text] [Related]
13. Adding Adjuvant Systemic Treatment after Neoadjuvant Therapy in Breast Cancer: Review of the Data.
Patel SA; DeMichele A
Curr Oncol Rep; 2017 Aug; 19(8):56. PubMed ID: 28733827
[TBL] [Abstract][Full Text] [Related]
14. Randomized Trial of Standard Adjuvant Chemotherapy Regimens Versus Capecitabine in Older Women With Early Breast Cancer: 10-Year Update of the CALGB 49907 Trial.
Muss HB; Polley MC; Berry DA; Liu H; Cirrincione CT; Theodoulou M; Mauer AM; Kornblith AB; Partridge AH; Dressler LG; Cohen HJ; Kartcheske PA; Perez EA; Wolff AC; Gralow JR; Burstein HJ; Mahmood AA; Sutton LM; Magrinat G; Parker BA; Hart RD; Grenier D; Hurria A; Jatoi A; Norton L; Hudis CA; Winer EP; Carey L
J Clin Oncol; 2019 Sep; 37(26):2338-2348. PubMed ID: 31339827
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant addition of capecitabine to early-stage triple-negative breast cancer patients receiving standard chemotherapy: a meta-analysis.
Li Y; Zhou Y; Mao F; Lin Y; Zhang X; Shen S; Sun Q
Breast Cancer Res Treat; 2020 Feb; 179(3):533-542. PubMed ID: 31865475
[TBL] [Abstract][Full Text] [Related]
16. Elderly woman with triple-negative metastatic breast cancer successfully treated with metronomic capecitabine.
De Iuliis F; Salerno G; Taglieri L; Vicinanza R; Lanza R; Scarpa S
Anticancer Res; 2014 Aug; 34(8):4287-91. PubMed ID: 25075060
[TBL] [Abstract][Full Text] [Related]
17. Clinical Value of Capecitabine-Based Combination Adjuvant Chemotherapy in Early Breast Cancer: A Meta-Analysis of Randomized Controlled Trials.
Chen G; Guo Z; Liu M; Yao G; Dong J; Guo J; Ye C
Oncol Res; 2017 Nov; 25(9):1567-1578. PubMed ID: 28337954
[TBL] [Abstract][Full Text] [Related]
18. Suggestions Regarding the GEICAM/2003-11_CIBOMA/2004-01 Trial: Future Treatment Options for Early Triple-Negative Breast Cancer.
Usui Y; Ishiki H; Shimomura A; Satomi E
J Clin Oncol; 2020 Jun; 38(18):2111-2112. PubMed ID: 32352859
[No Abstract] [Full Text] [Related]
19. Addition of Capecitabine to Adjuvant Chemotherapy May be the Most Effective Strategy for Patients With Early-Stage Triple-Negative Breast Cancer: A Network Meta-Analysis of 9 Randomized Controlled Trials.
Li Z; Zheng J; Ji Z; Chen L; Wu J; Zou J; Liu Y; Lin W; Cai J; Chen Y; Chen Y; Lu H
Front Endocrinol (Lausanne); 2022; 13():939048. PubMed ID: 35957836
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant Capecitabine In Triple Negative Breast Cancer: The Earlier, The Better?
Guven DC; Taban H; Dizdar O
J Oncol Pharm Pract; 2022 Jan; 28(1):203-204. PubMed ID: 34628993
[No Abstract] [Full Text] [Related]
[Next] [New Search]
